Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply  by Rozanski, Alan & Blumenthal, James
7. Lemery R, Soucie L, Martin B, et al. Human study of biatrial electrical
coupling: determinants of endocardial septal activation and conduction
over interatrial connections. Circulation 2004;110:2083–9.
Letters to the Editor
Cardiac Rehabilitation, Exercise
Training, and Psychosocial Risk Factors
The recent review by Rozanski et al. (1) outlined the important
role of behavioral and psychosocial risk factors in the pathogenesis
and expression of cardiovascular (CV) diseases, particularly coro-
nary artery disease (CAD). Although the investigators briefly
mentioned the potential for exercise training to improve prognosis
in patients with depression, as well as the role of adding psycho-
social intervention to standard cardiac rehabilitation programs to
reduce subsequent major CAD events (1,2), they mainly empha-
sized the role of behavioral and psychopharmacologic interven-
tions.
Formal phase II cardiac rehabilitation and exercise training pro-
grams, however, are known to produce marked benefits on exercise
capacity, plasma lipids, obesity indices, inflammation, metabolic
syndrome, autonomic function, blood viscosity and rheology, mea-
sures of ventricular repolarization dispersion, subsequent hospitaliza-
tion costs, as well as major CV morbidity and mortality (3–5). In
addition to producing over 50% reductions in the prevalence of
depressive symptoms (6–9), we have also demonstrated that formal
cardiac rehabilitation programs, with general but without specific
psychosocial intervention, also produced nearly 50% reductions in
both prevalence of hostility symptoms (10,11) and high levels of
anxiety symptoms (12) as well as markedly reducing somatization and
all aspects of psychological distress. In our studies, patients with
adverse behavioral factors generally had other adverse CAD risk
profiles, including low exercise capacities, hypertriglyceridemia, low
high-density lipoprotein cholesterol levels, elevated plasma glucose,
and reduced quality of life scores compared with patients without
these adverse psychological factors, and all these parameters markedly
improved following formal cardiac rehabilitation and exercise training
programs.
We agree with Rozanski et al. (1) that further emphasis on
the emerging importance of psychosocial and behavioral risk
factors is needed and that a sophisticated healthcare delivery
system may be needed to optimize intervention in these
disorders. However, we also believe that greater physician input
is needed to increase referrals, attendance, and completion of
the readily available and proven, yet greatly underutilized,
cardiac rehabilitation and exercise training programs to enhance
psychosocial and behavioral adaptation and the secondary
prevention of CAD.
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REPLY
We agree with Drs. Lavie and Milani that exercise is a
well-established intervention for the secondary prevention of
coronary heart disease (CHD), and is a major component of
cardiac rehabilitation programs (1,2). We also are aware that
cardiac rehabilitation services are seriously underutilized. For
example, according to a recent position paper from the Amer-
ican Heart Association (3) only 10% to 20% of eligible patients
actually participate in cardiac rehabilitation. A meta-analysis (4)
reported results from 32 studies with 16,804 patients eligible for
cardiac rehabilitation and reported that only 25% to 31% of
eligible men and 11% to 20% of eligible women participated. It
is evident that many physicians do not refer patients to cardiac
rehabilitation, and this reluctance is especially true for women
and minorities (5).
As alluded to by Drs. Lavie and Milani, exercise cannot only
induce beneficial physiological adaptations, but can also im-
prove psychological functioning. For example, in a recent
randomized trial, exercise training decreased depressive symp-
toms as effectively as antidepressant medication in patients with
clinical depression (6,7). Other work by Thayer et al. (8) has
demonstrated that even short bursts of exercise activity can
effectively increase energy or decrease tension for two-hour
periods. Recent data also emphasize the beneficial effects of
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exercise on cognitive function and brain plasticity (9). However,
because poor adherence to exercise training is relatively com-
mon, effective strategies for optimizing patient adherence are
needed (10).
It also should be noted that, though there is an extensive
literature documenting the value of exercise in patients with
coronary artery disease (CAD), data regarding the significance of
stress-management training in improving clinical outcomes are
limited. A nonrandomized trial of patients with stable CHD
showed that stress-management training was associated with
reduced ischemia, fewer cardiac events, and lower medical costs
compared to usual care controls (11,12). In the absence of data
from large multicenter randomized clinical trials with “hard”
clinical end points, we advocate for smaller studies using interme-
diate biomarkers of cardiovascular risk (13). For example, in a
recent study (14) both exercise and stress-management training
were found to reduce myocardial ischemia and improve vascular
endothelial function, compared to usual care. Furthermore, stress
management was actually superior to exercise training in improv-
ing measures of heart rate variability and baroreflex sensitivity.
These data would strongly support the potential clinical benefits of
both exercise and stress management in the routine care of patients
with CHD.
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Hemodynamic Phenomenon
or Geometric Discrepancy?
The recent study by Li et al. (1) has several limitations. The
absence of information on functional capacities, symptoms, pre-
operative pressure data, or left ventricular (LV) function indices
limits the significance of the data.
Perioperative mortality increases when pulmonary artery
(PA) pressures exceed 60 mm Hg, which is the cutoff in
risk-stratification systems like the Euroscore. A cutoff of 40 mm
Hg overestimates the incidence of severe pulmonary hyperten-
sion (PHT). Significantly, 15 of 40 patients with prosthesis-
patient mismatch (PPM) had postoperative atrial fibrillation
(AF). The difference in mean gradients between the PPM and
non-PPM groups is merely statistical, but insignificant. The
investigators suggest a “simple” strategy of implanting a pros-
thesis to obtain an indexed effective orifice area (EOA) [EOAI]
1.2 cm2/m2. This arbitrary classification based on EOAI has
no surgical significance. There is no mention of valve annular
diameters, which is an important consideration in the choice of
prosthesis size. The EOAIs for the different prosthesis sizes are
unavailable.
Most patients have body surface areas (BSAs) between 1.5 and
2 m2. This translates to absolute EOAs between 1.8 and 2.4 cm2.
The minimum absolute EOA of any size 23 prosthesis is 2.54 cm2,
which produces an EOAI 1.2 cm2/m2. However, a 23-mm
mitral prosthesis is clearly hemodynamically restrictive. Most
surgeons would implant larger valves than these; it follows that no
patient should have PPM if an EOAI of 1.2 cm2/m2 is considered
the minimum! In consequence, the recommendations by Li et al.
(1) are nonspecific and impractical.
Twenty-one of 32 patients with preoperative PHT had PPM.
In essence, the smallest valves were implanted in those with large
BSAs and preoperative PHT. Naturally, many patients would have
residual PHT. Could the investigators have actually undersized the
prosthesis in many patients?
Native annular diameter places a major restriction on the
maximum implantable prosthesis size. Problems with dispropor-
tionately large mitral prostheses include LV outflow obstruction,
restriction of prosthetic mobility, circumflex artery and conduction
system injury. Complications like atrioventricular groove dehis-
cence and ventricular rupture with large valves are every surgeon’s
nightmare. A murine annulus will not take an elephantine pros-
thesis!
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